145 related articles for article (PubMed ID: 18385166)
1. Clinical predictors of pulmonary hypertension in sarcoidosis.
Bourbonnais JM; Samavati L
Eur Respir J; 2008 Aug; 32(2):296-302. PubMed ID: 18385166
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method.
Freitas CSG; Baldi BG; Jardim C; Araujo MS; Sobral JB; Heiden GI; Kairalla RA; Souza R; Carvalho CRR
Orphanet J Rare Dis; 2017 Apr; 12(1):74. PubMed ID: 28427470
[TBL] [Abstract][Full Text] [Related]
3. Sarcoidosis-associated pulmonary hypertension in patients with near-normal lung function.
Maimon N; Salz L; Shershevsky Y; Matveychuk A; Guber A; Shitrit D
Int J Tuberc Lung Dis; 2013 Mar; 17(3):406-11. PubMed ID: 23407231
[TBL] [Abstract][Full Text] [Related]
4. Predictors of exercise-induced oxygen desaturation in systemic sclerosis patients with interstitial lung disease.
Someya F; Mugii N; Hasegawa M; Yahata T; Nakagawa T
Respir Care; 2014 Jan; 59(1):75-80. PubMed ID: 23764864
[TBL] [Abstract][Full Text] [Related]
5. Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension.
Sulica R; Teirstein AS; Kakarla S; Nemani N; Behnegar A; Padilla ML
Chest; 2005 Sep; 128(3):1483-9. PubMed ID: 16162747
[TBL] [Abstract][Full Text] [Related]
6. Rising stars of DPLD survival: FVC and exercise desaturation (a single-center study).
Öztürk A; Kayacan O
Turk J Med Sci; 2018 Aug; 48(4):826-832. PubMed ID: 30119159
[TBL] [Abstract][Full Text] [Related]
7. A haemodynamic study of pulmonary hypertension in chronic hypersensitivity pneumonitis.
Oliveira RK; Pereira CA; Ramos RP; Ferreira EV; Messina CM; Kuranishi LT; Gimenez A; Campos O; Silva CM; Ota-Arakaki JS
Eur Respir J; 2014 Aug; 44(2):415-24. PubMed ID: 24743965
[TBL] [Abstract][Full Text] [Related]
8. Echocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis.
Modrykamien AM; Gudavalli R; McCarthy K; Parambil J
Respir Care; 2010 May; 55(5):584-8. PubMed ID: 20420729
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary hypertension in chronic lung diseases.
Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test.
Flaherty KR; Andrei AC; Murray S; Fraley C; Colby TV; Travis WD; Lama V; Kazerooni EA; Gross BH; Toews GB; Martinez FJ
Am J Respir Crit Care Med; 2006 Oct; 174(7):803-9. PubMed ID: 16825656
[TBL] [Abstract][Full Text] [Related]
11. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
Garin MC; Highland KB; Silver RM; Strange C
J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
[TBL] [Abstract][Full Text] [Related]
12. Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis.
Handa T; Nagai S; Miki S; Fushimi Y; Ohta K; Mishima M; Izumi T
Chest; 2006 May; 129(5):1246-52. PubMed ID: 16685015
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease.
Fonseca GH; Souza R; Salemi VM; Jardim CV; Gualandro SF
Eur Respir J; 2012 Jan; 39(1):112-8. PubMed ID: 21778170
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of walk distance, work, oxygen saturation, and dyspnea during 6-minute walk test in COPD patients.
Golpe R; Pérez-de-Llano LA; Méndez-Marote L; Veres-Racamonde A
Respir Care; 2013 Aug; 58(8):1329-34. PubMed ID: 23322886
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary hypertension in interstitial lung disease: prevalence, prognosis and 6 min walk test.
Andersen CU; Mellemkjær S; Hilberg O; Nielsen-Kudsk JE; Simonsen U; Bendstrup E
Respir Med; 2012 Jun; 106(6):875-82. PubMed ID: 22425136
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension associated with sarcoidosis.
Baughman RP
Arthritis Res Ther; 2007; 9 Suppl 2(Suppl 2):S8. PubMed ID: 17767746
[TBL] [Abstract][Full Text] [Related]
17. Oxygen desaturation during a 6-minute walk test as a predictor of maximal exercise-induced gas exchange abnormalities in sarcoidosis.
Chenivesse C; Boulanger S; Langlois C; Wemeau-Stervinou L; Perez T; Wallaert B
J Thorac Dis; 2016 Aug; 8(8):1995-2003. PubMed ID: 27621852
[TBL] [Abstract][Full Text] [Related]
18. Impaired 6-min walk test, heart rate recovery and cardiac function post pulmonary embolism in long-term survivors.
Chow V; Ng AC; Seccombe L; Chung T; Thomas L; Celermajer DS; Peters M; Kritharides L
Respir Med; 2014 Oct; 108(10):1556-65. PubMed ID: 25154698
[TBL] [Abstract][Full Text] [Related]
19. [Importance of lung function for pulmonary hypertension in sarcoidosis].
Held M; Jonas-Klemm D; Jany BH
Pneumologie; 2013 Sep; 67(9):502-8. PubMed ID: 24006196
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.
Kimura M; Taniguchi H; Kondoh Y; Kimura T; Kataoka K; Nishiyama O; Aso H; Sakamoto K; Hasegawa Y
Respiration; 2013; 85(6):456-63. PubMed ID: 23257350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
